Hydrogen Research Study
← Back to Research Library
Preclinical animal evidenceAnimal studyInjected or infused hydrogen

Hyperoxygenated hydrogen-rich solution suppresses shock- and resuscitation-induced liver injury.

Dang Y, Liu T, Mei X, Meng X, Gou X, Deng B, Xu H, Xu L · The Journal of surgical research · 2017

Research-use notice

Independent study record

Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

H2HUBB Research Library branded molecular hydrogen research image
Primary topic Liver and Fatty Liver Disease
Evidence type Preclinical animal evidence
Publication type Animal study
Hydrogen method Injected or infused hydrogen
injected hydrogen fatty liver disease study 2017 research summary

The publication “Hyperoxygenated hydrogen-rich solution suppresses shock- and resuscitation-induced liver injury.” is organized in H2HUBB under the research focus injected hydrogen fatty liver disease study 2017. The publication is cited as Dang Y, Liu T, Mei X, Meng X, Gou X, Deng B, Xu H, Xu L, The Journal of surgical research, 2017. This animal study examined Hyperoxygenated hydrogen-rich solution suppresses shock- and resuscitation-induced liver injury. The abstract describes Rat model; hydrogen delivered as injected or infused hydrogen. The abstract reports: HHOS has protective effects against liver injury in a rat model of HSR. This is an automated editorial draft based on the abstract and requires source review before publication.

Injected hydrogen fatty liver disease study 2017 overview

It is not known whether simultaneous delivery of hydrogen and oxygen can reduce injury caused by hemorrhagic shock and resuscitation (HSR). This study investigated… Animal research can identify biological effects and support future investigation, but it cannot by itself establish safety or effectiveness in humans.

Study design and hydrogen intervention

Publication type: Animal study. Evidence type: Preclinical animal evidence. Research model or population: Rat model. Blinding: Unknown. Control status: Unknown.

Delivery method: Injected or infused hydrogen.

Reported findings and scientific interpretation

For this injected hydrogen fatty liver disease study 2017, the study record reports the following: The abstract reports: HHOS has protective effects against liver injury in a rat model of HSR.

These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.

How this research record was prepared

H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.

Limitations, safety, and original source

Limitations: Preclinical animal findings may not translate directly to human outcomes.

Safety: The abstract did not provide detailed safety or adverse-event information.

This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.